Preexisting Allergic Disease May Increase Risk for Long COVID
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 15, 2023 -- Preexisting asthma or rhinitis may increase the risk for long COVID (LC), according to a review published online Nov. 8 in Clinical & Experimental Allergy.
Doreen Wolff, from the University of Magdeburg in Germany, and colleagues conducted a systematic literature review to examine the epidemiological evidence on allergic diseases as risk factors for LC.
Based on 13 studies (9,967 participants; range, 39 to 1,950 per study), the researchers found that the evidence supported a possible relationship between LC and allergy but was very uncertain. The proportion of people with LC ranged from 11 to 90 percent. In hospital-based populations (six studies; 4,019 participants), the researchers found preexisting asthma measured may be associated with an increased risk for LC (odds ratio, 1.94), with very low certainty. Findings were similar for preexisting rhinitis (three studies; 1,141 participants; odds ratio, 1.96), with very low certainty. All studies had a high risk for bias due to population selection and methods used to ascertain the exposures and the outcome.
"The allergy community should be aware that individuals with asthma or rhinitis might be at increased risk of LC after severe acute respiratory syndrome coronavirus 2 infection," the authors write.
One author is the principal investigator of the StopCOVID observational cohort study and co-leads the PC-COS project, developing the Core Outcome Set for post-COVID-19 condition.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Further Support and Information on COVID-19
Read this next
Following Drop After COVID-19 Onset, Inappropriate Antibiotic Prescribing Is Up
WEDNESDAY, May 1, 2024 -- There was an initial decrease in inappropriate antibiotic prescriptions following onset of COVID-19, followed by an increase, according to a study...
Long-Term Smell, but Not Taste, Deficits Seen After COVID-19
WEDNESDAY, May 1, 2024 -- Olfactory dysfunction, especially for smell, is more common in individuals with prior COVID-19 versus individuals with no history of infection, with...
SARS-CoV-2 Vaccine Does Not Increase New-Onset Seizure Risk
TUESDAY, April 30, 2024 -- There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.